Biomarin Pharmaceutical Inc
NASDAQ: BMRN
$67.07
+$0.13 (+0.2%)
Closing Price on November 8, 2024
BMRN Articles
These four top companies could be very attractive to large cap biotechs looking to add gene and cell therapy drugs to their portfolios.
Published:
Last Updated:
Merrill Lynch has taken a look at the biotech industry and made a few picks that could play out in 2018.
Published:
Last Updated:
Here 24/7 Wall St. has included a calendar of a few of the biggest companies expecting clinical trial and FDA updates in February.
Published:
Last Updated:
Credit Suisse sees tax reform sparking a wave of mergers in the emerging pharmaceuticals space, which could produce sector outperformance. The firm is cautiously optimistic on this front.
Published:
Last Updated:
The include Abercrombie & Fitch, Arch Coal, Baker Hughes, BioMarin Pharmaceutical, Gilead Sciences, Hasbro and Snap.
Published:
Last Updated:
24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of July and added some color.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations include ConocoPhillips, Goodyear Tire, Humana, Lululemon Athletica and Range Resources.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday, include Best Buy, Caterpillar, Nokia, UnitedHealth and Wal-Mart.
Published:
Last Updated:
In a new report, SunTrust Robinson Humphrey analysts are focused on upcoming catalysts for biotech stocks in their coverage universe.
Published:
Last Updated:
BioMarin Pharmaceutical may have missed out on the Trump rally, but it might not be too late to catch a ride on the wave, at least according to one analyst.
Published:
Last Updated:
A recent research report from the biotech team at Baird offers their top picks for 2017. While hardly pounding the table, they are cautiously optimistic on the industry.
Published:
Last Updated:
In a new research report, the biotech team at RBC reveal their top picks for 2017, and while hardly pounding the table, they are cautiously optimistic.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include AK Steel, Celgene, Darden Restaurants, Delphi Automotive, Johnson & Johnson and U.S. Steel.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday morning include GoPro, Randgold Resources, Teva Pharmaceutical, Time Warner, Waste Management.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Brocade Communications Systems, Facebook, First Solar, Fitbit, ONEOK Partners and Sunrun.
Published:
Last Updated: